Loading stock data...

Kobo Biotech Ltd.

BSE: KOBO

BSE
2.55 0.12 (4.94%)

Prev Close

2.43

Open Price

2.55

Volume

104

Today Low / High

2.55 / 2.55

52 WK Low / High

2.2 / 4.34

Range

2 - 3

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 2.55, reflecting a change of 0.12 (4.93827%). The expected target range on the BSE is 2 - 3. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

11 Aug 2.58 -2.33%
08 Aug 2.43 1.23%
07 Aug 2.54 0.39%
06 Aug 2.47 2.02%
05 Aug 2.20 9.55%
04 Aug 2.38 -2.94%
01 Aug 2.43 -4.12%
31 Jul 2.55 -4.71%
30 Jul 2.60 -1.92%
29 Jul 2.74 -9.49%
28 Jul 2.56 1.95%
25 Jul 2.56 -1.56%
24 Jul 2.45 -0.41%
23 Jul 2.31 1.30%
22 Jul 2.59 -6.95%
21 Jul 2.48 2.02%

Kobo Biotech Ltd. Graph

Kobo Biotech Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Kobo Biotech Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2.55, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 2.55 2.58 2.32 - 2.83
2.60 2.08 - 3.12
2.63 1.84 - 3.41
Bearish Scenario 2.55 2.52 2.27 - 2.78
2.50 2.00 - 3.00
2.47 1.73 - 3.22

Overview of Kobo Biotech Ltd.

ISIN

INE881A01015

Industry

Medical - Pharmaceuticals

Vol.Avg

11,315

Market Cap

60,039,000

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for KOBO

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 0.00 Cr 4.07 Cr -4.07 Cr 0.0000 0.00 Cr 0.00 Cr -0.25 Cr -4.93 Cr -2.07 -0.86 Cr 0.0000
2023-03-31 0.00 Cr 4.07 Cr -4.07 Cr 0.0000 0.00 Cr 0.11 Cr -5.02 Cr -5.55 Cr -2.33 -1.48 Cr 0.0000
2022-03-31 0.00 Cr 4.61 Cr -4.61 Cr 0.0000 0.00 Cr 0.08 Cr -109.11 Cr -15.23 Cr -6.39 -10.49 Cr 0.0000
2021-03-31 0.00 Cr 5.64 Cr -5.64 Cr 0.0000 0.00 Cr 0.00 Cr -1.39 Cr -19.23 Cr -8.07 -2.75 Cr 0.0000
2020-03-31 0.00 Cr 5.88 Cr -5.88 Cr 0.0000 0.00 Cr 0.00 Cr -8.49 Cr -21.01 Cr -8.82 -2.61 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 0.18 Cr 71.39 Cr 204.30 Cr -132.9103 Cr 139.69 Cr 139.51 Cr 18.04 Cr 33.52 Cr 0.00 Cr 0.00 Cr 0.00 Cr 167.8223 Cr
2023-03-31 0.08 Cr 75.33 Cr 203.31 Cr -128.1815 Cr 139.84 Cr 139.76 Cr 18.04 Cr 37.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 165.8840 Cr
2022-03-31 0.08 Cr 79.19 Cr 201.61 Cr -122.6281 Cr 140.72 Cr 140.63 Cr 18.04 Cr 41.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 163.3118 Cr
2021-03-31 1.52 Cr 230.59 Cr 337.79 Cr -107.4022 Cr 260.53 Cr 259.01 Cr 53.28 Cr 59.16 Cr 0.00 Cr 0.00 Cr 12.20 Cr 299.1577 Cr
2020-03-31 0.13 Cr 236.33 Cr 324.31 Cr -88.1709 Cr 250.77 Cr 250.64 Cr 53.28 Cr 64.79 Cr 0.00 Cr 0.00 Cr 12.20 Cr 284.2743 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 0.2036 Cr 0.0000 Cr -0.1500 Cr 0.2036 Cr 0.0536 Cr 0.1805 Cr -0.2036 Cr -4.9288 Cr 0.7960 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 0.8746 Cr 0.0000 Cr -0.8740 Cr 0.8746 Cr 0.0006 Cr 0.0841 Cr 0.0000 Cr -5.5534 Cr -0.8740 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 93.6226 Cr 25.0904 Cr -120.1465 Cr 93.6226 Cr -1.4335 Cr 0.0835 Cr 0.0000 Cr -15.2259 Cr -119.8155 Cr 0.0000 Cr 35.2381 Cr
2021-03-31 -7.9692 Cr 0.0000 Cr 9.4012 Cr -7.9692 Cr 1.3892 Cr 1.5170 Cr 0.0000 Cr -19.2313 Cr -1.3988 Cr 0.0000 Cr 0.0000 Cr
2020-03-31 -14.3990 Cr -0.0027 Cr 14.4000 Cr -14.4017 Cr -0.0017 Cr 0.1278 Cr -0.0027 Cr -21.0062 Cr 14.4000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-06-30 0.00 Cr 1.01 Cr -1.01 Cr 0.0000 -0.07 Cr -1.33 Cr -0.56 -0.32 Cr 0.0000
2024-03-31 0.00 Cr 1.01 Cr -1.01 Cr 0.0000 -1.26 Cr -1.26 Cr -0.53 -0.25 Cr 0.0000
2023-12-31 0.00 Cr 1.03 Cr -1.03 Cr 0.0000 -1.23 Cr -1.23 Cr -0.52 -0.20 Cr 0.0000
2023-09-30 0.00 Cr 1.02 Cr -1.02 Cr 0.0000 -1.22 Cr -1.22 Cr -0.51 -0.20 Cr 0.0000
2023-06-30 0.00 Cr 1.01 Cr -1.01 Cr 0.0000 -1.24 Cr -1.23 Cr -0.51 -0.21 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-06-30 0.00 Cr 0.00 Cr 0.18 Cr 0.00 Cr 0.00 Cr 0.18 Cr 0.00 Cr 0.00 Cr 132.91 Cr
2024-03-31 0.18 Cr 0.00 Cr 0.18 Cr 11.97 Cr 18.04 Cr 37.88 Cr 33.52 Cr 71.39 Cr 204.30 Cr
2023-12-31 -0.13 Cr 0.25 Cr 0.13 Cr 0.00 Cr 0.00 Cr 0.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.08 Cr 0.04 Cr 0.13 Cr 11.95 Cr 18.04 Cr 37.78 Cr 35.56 Cr 73.34 Cr 203.76 Cr
2023-06-30 -0.13 Cr 0.25 Cr 0.13 Cr 0.00 Cr 0.00 Cr 0.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.00 Cr 2.06 Cr 0.00 Cr 0.00 Cr 2.06 Cr 2.14 Cr 0.08 Cr 0.00 Cr 2.06 Cr
2023-09-30 0.00 Cr -1.22 Cr 0.00 Cr 0.00 Cr -1.22 Cr 0.08 Cr 1.30 Cr 0.00 Cr -1.22 Cr
2023-06-30 0.00 Cr -1.23 Cr 0.00 Cr 0.00 Cr -1.31 Cr -1.23 Cr 0.08 Cr 0.00 Cr -1.23 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹804.05 ₹96,279,696,851.00 ₹756,659.00

Key Executives

Chief Financial Officer
Mr. Neelam Kumar Murdia

Gender: male

Year Born:

Compliance Officer & Non-Executive Director
Mr. Rajendra Kumar P. Kaimal

Gender: male

Year Born: 1973

FAQs about Kobo Biotech Ltd.

Who is the CEO of the company?

The CEO is Neelam Kumar Murdia.

What is the current market price of the stock?

The current price is ₹2.52.

What is the 52-week price range?

The range is ₹2.2-4.34.

What is the market capitalization of the company?

The market capitalization is ₹6.00 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -2.31.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Kobo Biotech Ltd. (ISIN: INE881A01015) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹6.00 crores and an average daily volume of 11,315 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack